Safety and tolerability of 13-valent pneumococcal conjugate vaccine in healthy Chinese adults, children and infants.

@article{Zhu2015SafetyAT,
  title={Safety and tolerability of 13-valent pneumococcal conjugate vaccine in healthy Chinese adults, children and infants.},
  author={Feng-cai Zhu and Yuemei Hu and Q Y Liang and Mariano M Young and Xin Zhou and Zhangjing Chen and John Z Liang and William C. Gruber and Daniel J Scott},
  journal={Therapeutic advances in drug safety},
  year={2015},
  volume={6 6},
  pages={
          206-11
        }
}
OBJECTIVE Pneumococcal disease is a global problem, including in China. The objective of this study was to provide safety data for single-dose 13-valent pneumococcal conjugate vaccine (PCV13) in Chinese subjects, needed to begin a phase III safety and immunogenicity study in Chinese infants. METHODS Healthy Chinese adults (18-55 years), children (3-5… CONTINUE READING